Clinical trial outcomes for SLE: what we have and what we need Laurent Arnaud, Ioannis Parodis, Hervé Devilliers, Francois Chasset
15 February 2024
Evaluation of RNase therapy in systemic lupus erythematosus: a randomised phase 2a clinical trial of RSLV-132 Daniel J Burge, Victoria P Werth, Susan A Boackle, James Posada
7 February 2024
Fragility of randomised controlled trials for systemic lupus erythematosus and lupus nephritis therapies Gabriel Figueroa-Parra, Michael S Putman, Cynthia S Crowson, Alí Duarte-García
10 January 2024
Mezagitamab in systemic lupus erythematosus: clinical and mechanistic findings of CD38 inhibition in an autoimmune disease Scott R P McDonnell, Van Anh Nguyen, Noah M Walton, Carsten Merkwirth, Feng Hong, Deborah Berg, Elena Tomaselli Muensterman, Richard A Furie
7 March 2024
Systemic lupus in the era of machine learning medicine Kevin Zhan, Katherine A Buhler, Irene Y Chen, Marvin J Fritzler, May Y Choi
4 March 2024
Rituximab as an effective add-on maintenance therapy for disease activities in childhood-onset systemic lupus erythematosus Ting-Wei Lin, Yu-Tsan Lin, Ya-Chiao Hu, Hsin-Hui Yu, Bor-Luen Chiang
19 January 2024
Prevalence of coeliac disease in patients with systemic lupus erythematosus: a systematic review and meta-analysis Adonis Sotoodeh, Madeleine Nguyen Hoang, Karin Hellgren, Anders Forss
13 February 2024
Therapeutic drug monitoring of mycophenolic acid and clinical outcomes of lupus nephritis: a systematic review and meta-analysis Thunyatorn Wuttiputhanun, Nuanjanthip Naiyarakseree, Suwasin Udomkarnjananun, Wonngarm Kittanamongkolchai, Leelahavanichkul Asada, Pajaree Chariyavilaskul, Natavudh Townamchai, Yingyos Avihingsanon
17 January 2024
Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeks Binod Neupane, Pragya Shukla, Mahmoud Slim, Amber Martin, Michelle Petri, George K Bertsias, Alfred H J Kim, Antonis Fanouriakis, Roger A Levy, Deven Chauhan, Nick Ballew
5 May 2023
Clinical implications of discordance between anti-dsDNA antibodies by multiplex flow immunoassay and Crithidia luciliae assay in a multiethnic racial cohort of patients with SLE Devyn Zaminski, Amit Saxena, Peter Izmirly, Jill P Buyon, H Michael Belmont
14 November 2023
Efficacy and safety of telitacicept in patients with systemic lupus erythematosus: a multicentre, retrospective, real-world study Hui-Zhi Jin, Yu-jing Li, Xin Wang, Zhijun Li, Bin Ma, Lin Niu, Peng Wang, Hai-feng Pan, Si-dong Li, Wei Bao, Guosheng Wang, Xiao-mei Li, Zhu Chen
24 November 2023
SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort Iñigo Rua-Figueroa, M Jesus García de Yébenes, Julia Martinez-Barrio, Maria Galindo Izquierdo, Jaime Calvo Alén, Antonio Fernandez-Nebro, Raúl Menor-Almagro, Loreto Carmona, Beatriz Tejera Segura, Eva Tomero, Mercedes Freire-González, Clara Sangüesa, Loreto Horcada, Ricardo Blanco, Esther Uriarte ItzazelaiaSee the full list of authors
8 April 2024
Anifrolumab in lupus nephritis: results from second-year extension of a randomised phase II trial David Jayne, Brad Rovin, Eduardo Mysler, Richard Furie, Frédéric Houssiau, Teodora Trasieva, Jacob Knagenhjelm, Erik Schwetje, Weifeng Tang, Raj Tummala, Catharina Lindholm
22 August 2023
Steroid-sparing effect of belimumab: results from a retrospective observational study of real-world data Karen Worley, Scott Milligan, Bernard Rubin
22 December 2023
Interferon pathway in SLE: one key to unlocking the mystery of the disease Lars Rönnblom, Dag Leonard
19 January 2024
Novel multiclass classification machine learning approach for the early-stage classification of systemic autoimmune rheumatic diseases Yun Wang, Wei Wei, Renren Ouyang, Rujia Chen, Ting Wang, Xu Yuan, Feng Wang, Hongyan Hou, Shiji Wu
31 January 2024
Development and psychometric evaluation of a physician global assessment for type 2 systemic lupus erythematosus symptoms Megan E B Clowse, Jennifer L Rogers, Theresa Coles, David S Pisetsky, Lisa G Criscione-Schreiber, Dana Burshell, Jayanth Doss, Rebecca E Sadun, Kai Sun, Mithu Maheswaranathan, Amanda M Eudy
17 December 2023
Circulating neutrophil extracellular trap remnants as a biomarker to predict outcomes in lupus nephritis Laura Patricia Whittall-Garcia, Farnoosh Naderinabi, Dafna D Gladman, Murray Urowitz, Zahi Touma, Ana Konvalinka, Joan Wither
4 January 2024
Evaluating the real-world effectiveness of belimumab in patients with SLE using SLE-related laboratory values and rheumatoid arthritis-derived disease activity measures: RAPID3, swollen joint count and tender joint count Guillaume Germain, Karen Worley, Sean D MacKnight, Bernard Rubin, Christopher F Bell, François Laliberté, Ana Urosevic, Mei Sheng Duh, Andrew Concoff
3 April 2024
Enhanced medullary and extramedullary granulopoiesis sustain the inflammatory response in lupus nephritis Eleni Zervopoulou, Maria Grigoriou, Stavros A Doumas, Danae Yiannakou, Pavlos Pavlidis, Gilles Gasparoni, Jörn Walter, Anastasia Filia, Harikleia Gakiopoulou, Aggelos Banos, Ioannis Mitroulis, Dimitrios T Boumpas
11 March 2024